Table 3. Mean and median abundance of Staphylococcus aureus on ACV-treated forearms.

The median abundances are shown in the parentheses.

	Intention-to-treat		As-treated
	Healthy control	AD participant	Healthy control	AD participant
Baseline	0.01% (0.00%)	10.74% (1.16%) *	0.01% (0.00%)	5.73% (1.06%) *
2 weeks	0.05% (0.01%)	6.37% (0.81%) †	0.05% (0.02%)	3.61% (0.59%) †

* pairwise comparison vs healthy control at baseline, p < 0.05 by Wilcoxon rank-sum test.

† pairwise comparison vs healthy control at 2 weeks, p < 0.05 by Wilcoxon rank-sum test.